MI-217

• UNSPSC Description:

  MI-217 is a potent SIRT3 inhibitor. MI-217 induces MDA-MB-231 apoptosis. MI-217 can be used in the study of breast cancer[1].

• Target Antigen:

  Apoptosis; Sirtuin

• Type:

  Reference compound

• Related Pathways:

  Apoptosis;Cell Cycle/DNA Damage;Epigenetics

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/mi-217.html

• Smiles:

  S=C(N/N=C/C1=CC=C([N+]([O-])=O)C=C1)NCC

• Molecular Weight:

  252.29

• References & Citations:

  [1]Ullah A, et al. Identification of small molecular inhibitors of SIRT3 by computational and biochemical approaches a potential target of breast cancer. Sci Rep. 2024 May 30;14(1):12475.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported